CTCBIO Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.079x

CTCBIO Inc cash flow conversion efficiency. Based on the latest financial reports, CTCBIO Inc (060590) has a cash flow conversion efficiency ratio of 0.079x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.64 Billion ≈ $3.82 Million USD) by net assets (₩71.75 Billion ≈ $48.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of CTCBIO Inc (2013–2024)

Cash flow conversion efficiency of CTCBIO Inc from 2013 to 2024. This chart illustrates how CTCBIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 060590 share price today for real-time trading data and today's change.

CTCBIO Inc Cash Flow Conversion Ratio Explained

CTCBIO Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

CTCBIO Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CTCBIO Inc ranked by their cash flow conversion efficiency. Also see CTCBIO Inc (060590) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Gensource Potash Corporation V:GSP	-0.005x
Better Life Group Co Ltd TW:1805	0.002x
Nice Information & Telecommunication Inc KQ:036800	0.088x
Australian Unity Office Fund AU:AOF	-0.006x
Ctac N.V AS:CTAC	-0.292x
Kedawung Setia Industrial Tbk JK:KDSI	0.005x
Information and Communication Networks Public Company Limited BK:ICN	0.114x
Hanil Forging Industrial Co. Ltd KQ:024740	0.097x

Annual Cash Flow Conversion Efficiency for CTCBIO Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of CTCBIO Inc from 2013 to 2024. Review 060590 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩69.62 Billion ≈ $47.18 Million	₩4.50 Billion ≈ $3.05 Million	0.065x	-40.69%
2023-12-31	₩75.44 Billion ≈ $51.13 Million	₩8.22 Billion ≈ $5.57 Million	0.109x	-42.66%
2022-12-31	₩95.96 Billion ≈ $65.03 Million	₩18.22 Billion ≈ $12.35 Million	0.190x	+150.02%
2021-12-31	₩85.01 Billion ≈ $57.61 Million	₩6.46 Billion ≈ $4.38 Million	0.076x	+1036.38%
2020-12-31	₩76.32 Billion ≈ $51.72 Million	₩510.09 Million ≈ $345.68K	0.007x	-70.18%
2019-12-31	₩74.74 Billion ≈ $50.65 Million	₩1.68 Billion ≈ $1.14 Million	0.022x	+178.74%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩-2.47 Billion ≈ $-1.68 Million	-0.028x	-813.17%
2017-12-31	₩73.98 Billion ≈ $50.14 Million	₩295.30 Million ≈ $200.12K	0.004x	-94.71%
2016-12-31	₩90.89 Billion ≈ $61.60 Million	₩6.86 Billion ≈ $4.65 Million	0.076x	+420.86%
2015-12-31	₩99.14 Billion ≈ $67.19 Million	₩1.44 Billion ≈ $974.04K	0.014x	+456.42%
2014-12-31	₩85.49 Billion ≈ $57.94 Million	₩-347.74 Million ≈ $-235.66K	-0.004x	-113.69%
2013-12-31	₩92.23 Billion ≈ $62.50 Million	₩2.74 Billion ≈ $1.86 Million	0.030x	--

About CTCBIO Inc

KQ:060590 Korea Biotechnology

Market Cap

$42.37 Million

₩62.52 Billion KRW

Market Cap Rank

#22327 Global

#1421 in Korea

Share Price

₩2615.00

Change (1 day)

+1.16%

52-Week Range

₩2585.00 - ₩5500.00

All Time High

₩18000.00